These observations raise the hypothesis that heightened levels of Ang II originating from adipocytes may contribute to obesity-related dyslipidemia by modulating adipocyte SR-B1 expression and influencing HDL clearance. The gene discussed is AGT; the disease is metabolic syndrome.